Methadone and menopause: Midlife women in drug treatment

Journal of Social Work Practice in the Addictions

Volumn 3, Issue 2, 2003, Pages 43-55

  Tuchman, Ellen ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Addiction; Menopause; Methadone maintenance treatment; Social work; Women's health

Indexed keywords

EID: 34248606386     PISSN: 1533256X     EISSN: 15332578     Source Type: Journal    
DOI: 10.1300/J160v03n02_04     Document Type: Article

References (26)

1. Ball, J. R., 1991. The effectiveness of methadone maintenance treatment:Patients, programs, services, and outcomes. New York:Springer-Verlag.
2. Beth Israel Medical Center. 2000. Age distribution of patients enrolled in methadone maintenance treatment programs New York:NY:MMTP.
3. Brecher, E. M., and the Editors of Consumer Reports. 1972. Licit and illicit drugs:Consumers union report on narcotics, stimulants, depressants, inhalants, hallucinogens, and marijuana. Boston, MA:Little Brown and Company.
4. Caplehorn, J. R., Bell, J., Kleinbaum, D. G., and Gebski, V. J., 1993. Methadone dose and heroin use during maintenance treatment. Addiction, 88:199–124.
5. Courtwright, D. T., Herman, J., and Des Jarlais, D., 1989. Addicts who survived. Knoxville:University of Tennessee Press.
6. D'Aunno, T., and Vaughn, T. E., 1992. Variations in methadone treatment practices:Results from a national study. Journal of the American Medical Association., 267(2):253–258.
7. Dennerstein, L., 1996. Well-being, symptoms and the menopausal transition. Maturitas, 23:147–157.
8. Eklund, C., Hiltunen, A. J., Melin, L., and Borg, S., 1997. Patient perceptions of psychological and physiological withdrawal symptoms and positive factors associated with gradual withdrawal from methadone maintenance treatment:A prospective study. Substance Use and Misuse., 32(11):1599–1618.
9. Goldsmith, M. A., Hunt, D. E., Lipton, D. S., and Strug, D. L., 1984. Methadone folklore:Beliefs about side effects and their impact on treatment. Human Organization, 43:330–340.
10. Hunter, M. S., 1993. Predictors of menopausal symptoms:Psychosocial aspects. Bailliere's Clinical Endocrinology and Metabolism., 7(1):33–45.
11. Hunter, M. S., 1996. Depression and menopause. British Medical Journal, 313:1217–1218. 1067
12. Judson, B. A., and Goldstein, A., 1982. Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers. Drug Alcohol Depend, 10:2–3. Oct-Nov,:–, 269–82
13. Kendall, S. R., 1996. Substance and shadow:Women and addiction. Cambridge, Massachusetts:Harvard University Press.
14. Kessler, R. C., Anthony, J. C., Blazer, D. G., Bromet, E., Eaton, W. W., Kendler, K. S., Swartz, M. S., Wittchen, H. U., and Zhao, S., 1997. The US national comorbidity survey:Overview and future directions. Editoriali, Epidemiologiae Psichiatria Sociale, 6:4–16.
15. Kreek, M. J., 1973. Medical safety and side effects of methadone in tolerant individuals. Journal of the American Medical Association., 223:665–668.
16. Lowinson, J. H., Payte, J. T., Salsitz, E., Joseph, H., Marion, I. J., and Dole, V. P., 1991. Methadone maintenance, substance abuse:A comprehensive textbook, 3rd Ed. Baltimore, MD
17. Marlatt, G. A., and Gordon, J. R., eds. 1985. Relapse prevention:Maintenance strategies in the treatment of addictive behaviors New York:Guilford.
18. McKinlay, J., McKinlay, S., and Brambilla, D., 1987. The relative contributions of endocrine changes and social circumstances to depression in middle-aged women. Journal of Health and Social Behavior, 28:345–363.
19. Newman, R. G., 1977. Methadone treatment in narcotic addiction:Program management, findings, and prospects for the future New York, NY:Academic Press.
20. New York State Office of Alcoholism and Substance Abuse Services (NYS O ASAS). 2000.
21. Rosenbaum, M., 1987. Not the picture of health:Women on methadone. Journal of Psychoactive Drugs., 19(2):217–226.
22. Singh, N., Squier, C., Sivek, C., Wagener, M., and Yu, V., 1997. Psychological stress and depression in older patients with intravenous drug use and human immunodeficiency virus infection:implications for intervention. International Journal of STD/AIDS, 8:251–255.
23. Strain, E. C., Stitzer, M. L., Liebson, I. A., and Bigelow, G. E., 1993. Methadone dose and treatment outcome. Drug and Alcohol Dependence, 33:105–117.
24. Straussner, S. L. A., and Zelvin, E., 1997. Gender and Addiction:Men and Women in Treatment. Northville, N.J.:Jason Aronson.
25. Substance Abuse and Mental Health Services Administration (SAMSHA). 2001. Federal Register, DASIS Series S-11, DHHS Publication No. (SMA) 00–3463
26. Torgerson, D. J., Campbell, M. K., Thomas, R. E., and Reid, David M., 1997. Alcohol consumption may influence onset of the menopause. British Medical Journal, 315:188–194.